thrasher, as you have identified, starpharma seems to have a number of opportunities to develop over the comings 12-24 months.
These will require funding. Any and all revenue will be banked and earmarked as growth capital. There will be no capital returns (dividends nor buybacks) for the foreseeable future.
- Forums
- ASX - By Stock
- SPL
- Looking Forward
Looking Forward, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.1¢ |
Change
0.002(2.25%) |
Mkt cap ! $37.49M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 9.0¢ | $111.8K | 1.228M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 161427 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.1¢ | 73897 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 161427 | 0.090 |
3 | 30436 | 0.089 |
1 | 100000 | 0.088 |
1 | 100000 | 0.087 |
2 | 119243 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 74140 | 3 |
0.092 | 75852 | 3 |
0.093 | 57013 | 3 |
0.095 | 28035 | 3 |
0.096 | 5000 | 1 |
Last trade - 13.49pm 25/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |